Robert W Hsieh

Title: Innovations by Robert W. Hsieh in Cancer Treatment

Introduction

Robert W. Hsieh is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment, particularly in addressing triple-negative breast cancer (TNBC). His innovative approach focuses on inhibiting specific cellular mechanisms to improve patient outcomes.

Latest Patents

Hsieh holds a patent for "Methods for treating triple-negative breast cancer." This invention is directed towards methods of treating TNBC in patients by administering an agent that inhibits the expression or activity of cyclin-dependent kinase 19 (CDK19). The patent outlines various embodiments, including the use of small molecule inhibitors, polynucleotides such as shRNA or siRNA, and proteins like antibodies. Notably, the agent does not inhibit the activity or expression of CDK8, which is crucial for targeted treatment.

Career Highlights

Throughout his career, Robert W. Hsieh has worked with prominent organizations, including Chan Zuckerberg Biohub, Inc. and Leland Stanford Junior University. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapies.

Collaborations

Hsieh has collaborated with notable professionals, including Michael F. Clarke. Their joint efforts have further advanced the understanding and treatment of complex diseases like cancer.

Conclusion

Robert W. Hsieh's innovative work in developing methods for treating triple-negative breast cancer showcases his dedication to improving patient care through scientific advancements. His contributions are vital in the ongoing fight against cancer.